Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZE
· Real-Time Price · USD
26.18
1.30 (5.23%)
At close: Sep 24, 2025, 3:59 PM
27.49
5.00%
After-hours: Sep 24, 2025, 07:31 PM EDT
5.23% (1D)
| Bid | 25.95 |
| Market Cap | 1.15B |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -120.8M |
| EPS (ttm) | -1.68 |
| PE Ratio (ttm) | -15.58 |
| Forward PE | -8.28 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 26.41 |
| Volume | 866,976 |
| Avg. Volume (20D) | 381,915 |
| Open | 25.31 |
| Previous Close | 24.88 |
| Day's Range | 24.97 - 27.65 |
| 52-Week Range | 6.71 - 27.65 |
| Beta | 3.09 |
| Ex-Dividend Date | n/a |
About MAZE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAZE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MAZE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+54.81%
Maze Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
2 months ago
+24.26%
Maze Therapeutics shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $17.
